168 related articles for article (PubMed ID: 16007623)
1. Case of maternally transmitted juvenile Huntington's disease with a very large trinucleotide repeat.
Papapetropoulos S; Lopez-Alberola R; Baumbach L; Russell A; Gonzalez MA; Bowen BC; Singer C
Mov Disord; 2005 Oct; 20(10):1380-3. PubMed ID: 16007623
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic features of Huntington's disease-like 2.
Walker RH; Jankovic J; O'Hearn E; Margolis RL
Mov Disord; 2003 Dec; 18(12):1527-30. PubMed ID: 14673892
[TBL] [Abstract][Full Text] [Related]
3. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
[TBL] [Abstract][Full Text] [Related]
5. Huntington's disease, case report.
Ivkosic A; Titlic M; Tadic T; Erceg I; Marovic A; Primorac D
Neurol Neurochir Pol; 2003; 37(1):235-41. PubMed ID: 12910844
[TBL] [Abstract][Full Text] [Related]
6. Huntington's disease-like 2 in Brazil--report of 4 patients.
Rodrigues GG; Walker RH; Brice A; Cazeneuve C; Russaouen O; Teive HA; Munhoz RP; Becker N; Raskin S; Werneck LC; Junior WM; Tumas V
Mov Disord; 2008 Nov; 23(15):2244-7. PubMed ID: 18816802
[TBL] [Abstract][Full Text] [Related]
7. MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.
Vymazal J; Klempír J; Jech R; Zidovská J; Syka M; Růzicka E; Roth J
J Neurol Sci; 2007 Dec; 263(1-2):20-5. PubMed ID: 17585943
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic characteristics of Mexican Huntington's disease patients.
Alonso ME; Ochoa A; Boll MC; Sosa AL; Yescas P; López M; Macias R; Familiar I; Rasmussen A
Mov Disord; 2009 Oct; 24(13):2012-5. PubMed ID: 19672992
[TBL] [Abstract][Full Text] [Related]
9. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM
Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067
[TBL] [Abstract][Full Text] [Related]
10. Re: Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Reynolds N
Mov Disord; 2008 Sep; 23(12):1795-6; author reply 1793. PubMed ID: 18548610
[No Abstract] [Full Text] [Related]
11. [Clinical and genetic study of juvenile form of Huntington's disease].
Zdzienicka E; Rakowicz M; Mierzewska H; Hoffman-Zacharska D; Jakubowska T; Poniatowska R; Sułek A; Waliniowska E; Zalewska U; Kulczycki J; Zaremba J
Neurol Neurochir Pol; 2002; 36(2):245-58. PubMed ID: 12046502
[TBL] [Abstract][Full Text] [Related]
12. Huntington's Disease-like 2 (HDL2) in North America and Japan.
Margolis RL; Holmes SE; Rosenblatt A; Gourley L; O'Hearn E; Ross CA; Seltzer WK; Walker RH; Ashizawa T; Rasmussen A; Hayden M; Almqvist EW; Harris J; Fahn S; MacDonald ME; Mysore J; Shimohata T; Tsuji S; Potter N; Nakaso K; Adachi Y; Nakashima K; Bird T; Krause A; Greenstein P
Ann Neurol; 2004 Nov; 56(5):670-4. PubMed ID: 15468075
[TBL] [Abstract][Full Text] [Related]
13. Variation of selective gray and white matter atrophy in Huntington's disease.
Jech R; Klempír J; Vymazal J; Zidovská J; Klempírová O; Růzicka E; Roth J
Mov Disord; 2007 Sep; 22(12):1783-9. PubMed ID: 17579363
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging in Huntington's disease.
Seppi K; Schocke MF; Mair KJ; Esterhammer R; Weirich-Schwaiger H; Utermann B; Egger K; Brenneis C; Granata R; Boesch S; Poewe W; Wenning GK
Mov Disord; 2006 Jul; 21(7):1043-7. PubMed ID: 16570300
[TBL] [Abstract][Full Text] [Related]
15. Excessive blinking as an initial manifestation of juvenile Huntington's disease.
Xing S; Chen L; Chen X; Pei Z; Zeng J; Li J
Neurol Sci; 2008 Sep; 29(4):275-7. PubMed ID: 18810605
[TBL] [Abstract][Full Text] [Related]
16. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
[TBL] [Abstract][Full Text] [Related]
17. Huntington disease in children: genotype-phenotype correlation.
Rasmussen A; Macias R; Yescas P; Ochoa A; Davila G; Alonso E
Neuropediatrics; 2000 Aug; 31(4):190-4. PubMed ID: 11071143
[TBL] [Abstract][Full Text] [Related]
18. DNA trinucleotide repeat expansion in neuropsychiatric patients.
Mohmood S; Sherwani A; Khan F; Khan RH; Azfer A
Med Sci Monit; 2003 Sep; 9(9):RA237-45. PubMed ID: 12960939
[TBL] [Abstract][Full Text] [Related]
19. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.
Aziz NA; Jurgens CK; Landwehrmeyer GB; ; van Roon-Mom WM; van Ommen GJ; Stijnen T; Roos RA
Neurology; 2009 Oct; 73(16):1280-5. PubMed ID: 19776381
[TBL] [Abstract][Full Text] [Related]
20. Huntington's disease as caused by 34 CAG repeats.
Andrich J; Arning L; Wieczorek S; Kraus PH; Gold R; Saft C
Mov Disord; 2008 Apr; 23(6):879-81. PubMed ID: 18307262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
